BBIO vs TM · rev $221.9M vs P/E 9.7, rev $234.60B
BridgeBio Pharma Inc (BBIO) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
BBIO currently screens at market cap $13.24B. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the BBIO and TM stock pages for the full models.
Not investment advice.